Standard Deduction

Business

AMD and GIGABYTE Forge Deeper Alliance, Bringing On-Device AI to Mainstream Gaming and Creator PCs

GIGABYTE is expanding its strategic partnership with AMD to launch a new generation of AI-enhanced gaming laptops, motherboards, and monitors. This collaboration integrates AMD's Ryzen AI and 3D V-Cache technologies directly into consumer hardware, aiming to deliver tangible benefits in gaming smoothness, system stability, and creative workflow acceleration.

Feb 2, 2026

Business

Navigating Economic Uncertainty: Nine Practical Strategies to Fortify Your Savings in 2026

Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.

Feb 2, 2026

FDA Rejects Aquestive's Oral Anaphylaxis Treatment, Leaving Patients Awaiting Epinephrine Alternative

The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.

Feb 2, 2026

Business

Eli Lilly Bets Nearly $2 Billion on Repertoire Immune Medicines to Pioneer Next-Generation Autoimmune Therapies

Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.

Feb 2, 2026

Business

Billion-Pound Ambition Meets Market Reality: Xeinadin Sale Shelved as Bidders Balk at Price

Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.

Feb 2, 2026

Business

Waymo Eyes $16 Billion Funding at Near $110 Billion Valuation, Fueling Autonomous Vehicle Race

Alphabet's self-driving unit Waymo is in advanced talks to secure a massive $16 billion funding round, potentially valuing the company at around $110 billion, as competition in the robotaxi market intensifies.

Feb 2, 2026

Business

Essar Commits $100 Million to Boost Gas Output from Key Indian CBM Field

Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.

Feb 2, 2026

Business

Sonesta Unveils $400 Million Portfolio-Wide Revamp, Elevating Guest Experience Across Key Markets

Sonesta International Hotels concludes a sweeping multi-year renovation initiative, injecting modern amenities and design into properties from New York to Kaua'i, as the company sharpens its competitive edge in the hospitality sector.

Feb 2, 2026

Business

Analysts See Hidden Value in CuriosityStream: Stock Could Be Undervalued by Over 20%

A new financial analysis suggests shares of the documentary-focused streaming service CuriosityStream may be trading significantly below their estimated intrinsic value, presenting a potential opportunity for investors.

Feb 2, 2026

Business

NetEase Shares Dip: A Buying Opportunity or a Sign of Deeper Challenges?

Following a significant pullback, NetEase (SEHK: 9999) shares are trading at levels that some analysts deem undervalued. We examine the financial models, peer comparisons, and the broader sector headwinds facing the Chinese gaming giant to assess if the current price presents a strategic entry point for long-term investors.

Feb 2, 2026

Business

Cogent Biosciences Gains Key FDA Designations for Bezuclastinib, Spotlighting GIST Treatment Potential

Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.

Feb 2, 2026

Business

GXO Logistics Announces Executive Reshuffle, Appoints New COO and Interim Accounting Chief

GXO Logistics has unveiled a series of leadership changes, including the appointment of a new Chief Operating Officer and an interim Chief Accounting Officer, as the company sharpens its focus on operational execution and financial reporting quality amid intense industry competition.

Feb 2, 2026

Business

Church & Dwight's Valuation Puzzle: Is the Consumer Staples Giant Overpriced or Undervalued?

A deep dive into the conflicting signals from Church & Dwight's stock valuation. While a discounted cash flow model suggests a significant discount, its premium P/E ratio tells a different story, leaving investors to weigh pricing power against market expectations.

Feb 2, 2026

Business

Truist Financial Shares Trade at a Discount: Is the Market Overlooking Its Earnings Potential?

A deep dive into Truist Financial's valuation suggests its current share price may not fully reflect its underlying earnings power and book value, presenting a potential opportunity for investors.

Feb 2, 2026

Business

Analysts See Deep Value in Eos Energy Enterprises as Stock Trades at Steep Discount

A new valuation model suggests Eos Energy Enterprises' stock could be significantly undervalued, presenting a potential opportunity for investors amid a shifting energy policy landscape.

Feb 2, 2026

Business

Realty Income's 2026 Outlook: International Expansion and Portfolio Diversification Fuel Optimism

Following a strategic partnership with Singapore's GIC, Realty Income (NYSE: O) is poised for a transformative year. Analysts forecast further international growth, portfolio diversification into new property verticals, and a potential rebound in share performance as catalysts align.

Feb 2, 2026

Business

Guardian Pharmacy Services: Is the Stock Fairly Valued After Recent Gains?

A deep dive into Guardian Pharmacy Services (NYSE:GRDN) using a discounted cash flow model suggests its current share price is hovering close to its estimated intrinsic value. While the analysis provides a quantitative benchmark, investors are cautioned that valuation is just one piece of the puzzle in a complex and regulated healthcare sector.

Feb 2, 2026

US-Africa Trade Pact AGOA Granted Stopgap Reprieve, Long-Term Future Remains Uncertain

A last-minute, short-term extension of the cornerstone US-Africa trade program AGOA has been passed, averting immediate expiration but leaving businesses and governments on both continents anxious about the partnership's long-term trajectory.

Feb 2, 2026

World

Latin America's Balancing Act: Navigating the Surge of Chinese Imports

As Chinese exports, from electric vehicles to e-commerce parcels, flood Latin American markets, nations across the region are grappling with the dual pressures of protecting domestic industries and maintaining vital economic ties with Beijing.

Feb 2, 2026

Business

Kinsale Capital Group's Stock Slump: A Buying Opportunity or a Warning Sign After Q3?

Shares of specialty insurer Kinsale Capital have tumbled over 11% in six months, starkly underperforming the surging S&P 500. As investors digest its latest earnings, the debate intensifies: Is this a rare chance to buy a high-growth company at a discount, or a signal of deeper challenges ahead?

Feb 2, 2026